Sara Nik

Item: Sara Nik
Rating: 1.81
Author: StockAnalysis.com

Stock Analyst at HC Wainwright & Co.

(1.81)

# 3,163

Out of 4,996 analysts

Total ratings

50%

Success rate

3.65%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Sara Nik

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CDTX Cidara Therapeutics	Maintains: Buy	$74 → $110	$90.50	+21.55%	2	Sep 26, 2025
	MBRX Moleculin Biotech	Reiterates: Buy	$4	$0.49	+713.17%	2	Sep 10, 2025

Cidara Therapeutics

Sep 26, 2025

Maintains: Buy

Price Target: $74 → $110

Current: $90.50

Upside: +21.55%

Moleculin Biotech

Sep 10, 2025

Reiterates: Buy

Price Target: $4

Current: $0.49

Upside: +713.17%